Key result
Aspirin intake was associated with lower cardiac troponin T and Creatine Kinases after myocardial infarction, suggesting a reduction in infarct size.
Why the study?
Does aspirin intake reduce biomarkers of myocardial infarction size in patients with MI?
Population
378 patients with myocardial infarction
Comparison
Protective dose of aspirin intake vs No aspirin intake
Design
Cohort
Authors
Loading...
May indicate smaller infarcts with pre-MI aspirin; leaves open confounding and needs randomized confirmation before practice change.
Observational (n=378)
Does aspirin intake reduce biomarkers of myocardial infarction size in patients with MI?
Prior aspirin intake at a protective dose is associated with smaller myocardial infarction size as indicated by lower cardiac biomarkers.
Sezavar et al. (2012) conducted an observational in Myocardial infarction (n=378). Aspirin intake vs. No aspirin intake was evaluated on Cardiac troponin T and Creatine Kinases. Aspirin intake was associated with lower cardiac troponin T and Creatine Kinases after myocardial infarction, suggesting a reduction in infarct size.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: